Evidence map›Paper›PMID 37291691›Full record

ReviewHuman vaccines & immunotherapeutics2023

Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present.

Elizabeth Hamson, Carol Forbes, Priscilla Wittkopf, Anuja Pandey, Diana Mendes, Jack Kowalik, Carole Czudek, Tendai Mugwagwa

Open access · goldAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Post-Pandemic Surge in Complications of Acute Otitis Media.Turkish archives of otorhinolaryngology · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Elizabeth HamsonUK Health and Value, Pfizer Ltd., Tadworth, UK.
Carol ForbesEvidence Synthesis, Evidera, London, UK.
Priscilla WittkopfEvidence Synthesis, Evidera, London, UK.
Anuja PandeyEvidence Synthesis, Evidera, London, UK.
Diana MendesUK Health and Value, Pfizer Ltd., Tadworth, UK.
Jack KowalikUK Health and Value, Pfizer Ltd., Tadworth, UK.
Carole CzudekVaccines Medical Affairs, Pfizer Ltd., Tadworth, UK.
Tendai MugwagwaUK Health and Value, Pfizer Ltd., Tadworth, UK.
Pfizer (United States) · USIthaka Harbors · USPfizer (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases are a leading cause of morbidity and mortality worldwide with vaccines playing a critical role in preventing deaths. To better understand the impact of low vaccination rates and previous epidemics on infectious disease rates, and how these may help to understand the potential impacts of the current coronavirus disease 2019 (COVID-19) pandemic, a targeted literature review was conducted. Globally, studies suggest past suboptimal vaccine coverage has contributed to infectious disease outbreaks in vulnerable populations. Disruptions caused by the COVID-19 pandemic have contributed to a decline in vaccination uptake and a reduced incidence in several infectious diseases; however, these rates have increased following the lifting of COVID-19 restrictions with modeling studies suggesting a risk of increased morbidity and mortality from several vaccine-preventable diseases. This suggests a window of opportunity to review vaccination and infectious disease control measures before we see further disease resurgence in populations and age-groups currently unaffected.

Indexed as

Communicable DiseasesCOVID-19VaccinesHumansPandemicsVaccinationVaccinesCOVID-19Infectious diseaseliterature reviewvaccination rates

Identifiers

PMID37291691
PMCPMC10332206
OpenAlexW4379966435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.